Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2001. Start Trial.
Date Value
October 23, 2026 4.383
October 22, 2026 4.423
October 21, 2026 4.320
October 20, 2026 4.373
October 19, 2026 4.272
October 16, 2026 4.276
October 15, 2026 4.234
October 14, 2026 4.134
October 13, 2026 3.996
October 12, 2026 4.052
October 09, 2026 4.016
October 08, 2026 4.020
October 07, 2026 4.061
October 06, 2026 4.025
October 05, 2026 4.020
October 02, 2026 4.062
October 01, 2026 4.075
September 30, 2026 4.160
September 29, 2026 4.262
September 28, 2026 4.292
September 25, 2026 4.253
September 24, 2026 4.288
September 23, 2026 4.293
September 22, 2026 4.381
September 21, 2026 4.412
Date Value
September 18, 2026 4.337
September 17, 2026 4.41
September 16, 2026 4.344
September 15, 2026 4.319
September 14, 2026 4.323
September 11, 2026 4.157
September 10, 2026 4.156
September 09, 2026 4.200
September 08, 2026 4.192
September 04, 2026 4.309
September 03, 2026 4.394
September 02, 2026 4.356
September 01, 2026 4.375
August 31, 2026 4.34
August 28, 2026 4.389
August 27, 2026 4.342
August 26, 2026 4.442
August 25, 2026 4.497
August 24, 2026 4.472
August 21, 2026 4.527
August 20, 2026 4.488
August 19, 2026 4.567
August 18, 2026 4.418
August 17, 2026 4.343
August 14, 2026 4.277

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
AstraZeneca PLC 11.24
Johnson & Johnson 7.789
Eli Lilly & Co. 35.39
Merck & Co., Inc. 8.552
Novo Nordisk A/S 5.101

Price to Book Value Related Metrics